Table 1.
Characteristics of the study samples
| All participants (%) | HEV-IgG (%) | p-value | HEV-IgM (%) | p-value | HEV-Ag (%) | p-value | HEV-Total (%) | p-value | RT-PCR (%) | p-value | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | |||||||||||
| Male | 159 (61.4%) | 54 (38.3%) | p = 0.01 | 16 (11.1%) | p = 0.00001 | 9 (8.10%) | p > 0.05 | 37 (41.6%) | p = 0.025 | 20 (28.6%) | p = 0.02 |
| Female | 100 (38.6%) | 20 (22.4%) | 4 (4.5%) | 1 (1.45%) | 16 (24.2%) | 4 (11.8%) | |||||
| Age | |||||||||||
| 0–24 | 38 (14.7%) | 11(28.9%) | p = 0.024 | 8 (21.1%) | p = 0.026 | 5 (13.1%) | p = 0.024 | 9 (23.7%) | p = 0.000011 | 7 (19.4%) | p > 0.05 |
| 25–34 | 65 (25.1%) | 14 (21.9%) | 3 (4.68%) | 2 (30.8%) | 9 (14.1%) | 7 (25%) | |||||
| 35–44 | 65 (25.1%) | 15 (23.0%) | 5 (7.69%) | 1 (1.53%) | 9 (20.45%) | 4 (14.3%) | |||||
| 45–54 | 40 (15.4%) | 12 (30.0%) | 4 (10.0%) | 2 (8.33%) | 11 (52.4%) | 4 (40%) | |||||
| 55+ | 40 (15.4%) | 20 (50%) | 0 | 0 | 15 (62.5%) | 2 (22.2%) | |||||
| NR | 11 (4.2%) | 2 (18.1%) | 0 | 0 | 0 | 0 | |||||
| Nationality | |||||||||||
| Indian subcontinent | 121 (46.7%) | 42 (38.8%) | p = 0.03 | 16 (14.6%) | p = 0.02 | 9 (10.3%) | p > 0.05 | 31 (43.7%) | p = 0.02 | 19 (36.5%) | p = 0.01 |
| West Asia | 79 (30.5%) | 16 (23.2%) | 1 (1.42%) | 1 (1.96%) | 10 (22.2%) | 2 (6.89%) | |||||
| South East Asia | 12 (4.63%) | 3 (27.3%) | 1 (10%) | 0 | 0 | 0 | |||||
| North Africa | 36 (13.9%) | 13 (39.4%) | 2 (6.25%) | 0 | 11 (40.7%) | 3 (23.1%) | |||||
| Others | 11 (4.25%) | 0 | 0 | 0 | 1 (16.7%) | 0 | |||||
| Total positive (%) | 74 (32.1) | 20 (8.65) | 10 (5.56) | 53 (34.2) | 24 (23.1) | ||||||
Bold p-value represents value < 0.05, which means significant